Back to search
FDAFDA · Food and drugs·Recall number D-0120-2021

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05

Published December 16, 2020 · Recall initiated: November 17, 2020

Summary

FDA records drug Class I recall D-0120-2021, published December 16, 2020 and initiated November 17, 2020. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 13,525 bottles; Lot: Lot #: 6123925. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with other products: trace amounts of lidocaine

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
USA Nationwide
Lot
Lot #: 6123925
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05 recalled?

Yes. FDA published recall D-0120-2021 on December 16, 2020. Reported hazard: Cross Contamination with other products: trace amounts of lidocaine

What should I do if I have this product?

Voluntary: Firm initiated · Letter